Freshfields

Jon Scurr

Deals
2
Latest
Sep 2026
Most deals in
Pharma

Firm

Often works with

Deals

US deals dated after 30 September 2026 are still being collected.

Columns
Deals Jon Scurr was named on, most recent first
Sep 2026 portfolio of 20 mature medicines and three manufacturing sites SanofiCheplapharmAsset saleLegal adviser to Sanofi (seller)Announced–Pharma+1Cheplapharm acquisition of portfolio of 20 mature medicines and three manufacturing sites
May 2026 Exclusive development and commercialisation rights to Idefirix in Europe and MENA Hansa Biopharma ABSERB PharmaceuticalsAsset saleLegal adviser to SERB Pharmaceuticals (acquirer)Pending133.6Pharma+1SERB Pharmaceuticals acquisition of Exclusive development and commercialisation rights to Idefirix in Europe and MENA

Deals where Jon Scurr is named on the firm's deal team, by the firm or the press.

Suggest a correction

A missing deal, a wrong firm, a move between firms, or two different people shown as one. A link to a public source helps.